Henry Schein, Inc.

HSIC Healthcare Medical Distribution

Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024.

Revenue
+3.95%
EPS
+34.8%
Free cash flow
−7.09%
Total debt
+15.6%

Quarter to September 2026, against a year earlier

86.21 0.90 +1.05%
Market cap
$9.4B
P/E
23.0×
Fwd P/E
21.3×
Dividend yield
—
F-score
5/9
Altman Z
2.66
Beneish M
−2.51
Dividend safety
69/100

Henry Schein, Inc. (HSIC) P/E ratio

Alert me on P/E ratio

As of 6 November 2026, Henry Schein, Inc. (HSIC) trades at a P/E ratio of 23.0×. Over the past ten years it has ranged from 9.1× (March 2020) to 31.7× (November 2024); the current reading is higher than 75% of that period. That is below the Healthcare sector median of 24.5×.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2025 22.9× 1.61%
FY2024 22.5× (5.14%)
FY2023 23.8× 17.31%
FY2022 20.3× 17.56%
FY2021 17.2× (27.07%)
FY2020 23.6× 67.49%
FY2019 14.1× (18.48%)
FY2018 17.3× (19.78%)
FY2017 21.6× 11.64%
FY2016 19.3× (9.99%)

Quarterly newest first

Period P/E ratio Change
Sep 2026 22.4× (7.30%)
Jun 2026 24.1× 9.39%
Mar 2026 22.1× (3.65%)
Dec 2025 22.9× 10.08%
43 more quarters

Against its own ten years

Low 9.1× High 31.7×
Ten-year median 20.8×
Current reading's percentile 73

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HSIC